Bottom line
What is EIVAX's expense ratio?
EIVAX's expense ratio is 0.81%, or about $81 a year on every $10,000 invested. That is cheaper than 50% of large value funds we track (median 0.81%). This share class also charges a front-end sales load of up to 5.75%, taken from your investment when you buy.
Updated Jul 1, 2026
EIVAX fee table
| Net expense ratio | 0.81% |
|---|---|
| Gross expense ratio | 0.87% |
| Management fee | 0.4% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.47% |
| Fee waiver / reimbursement | -0.06% |
| Max front-end sales load | 5.75% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Jul 1, 2026
What EIVAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| EIVAX | $653 | $825 | $1,018 | $1,575 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.81% expense ratio costs roughly $45,600 in lost growth, versus about $45,600 for the median large value fund (0.81%).